Tokyo, March 20 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060991) titled 'Development and validation of a questionnaire assessing control over perceptual experiences' on March 19.
Study Type:
Observational
Primary Sponsor:
Institute - The University of Tokyo
Condition:
Condition - Mental disorders including conditions with auditory hallucinations
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To develop the Japanese version of the Control Over Perceptual Experiences (COPE) Scale and to evaluate its psychometric properties, including reliability and validity.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
Gender - Male and Female
Key inclusion criteria - -Individuals aged 18 to 64 who have been diagnosed with a mental disorder, or those who have not received a formal diagnosis but experience mental symptoms such as auditory hallucinations, and who have experienced such hallucinations at least once a month within the past six months
-The anticipated diagnosis includes illnesses such as schizophrenia that may cause hallucinations or auditory hallucinations. The severity of the condition must be such that the individual is capable of responding to the survey
-Individuals who have consented to participate in the survey
Key exclusion criteria - -Individuals with paroxysmal disorders, cognitive impairment, or neurological disorders
-Individuals who regularly consume alcohol or non-prescription medications during the study period
Target Size - 180
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 02 Month 04 Day
Date of IRB - 2026 Year 02 Month 04 Day
Anticipated trial start date - 2026 Year 03 Month 19 Day
Last follow-up date - 2026 Year 10 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069785
Disclaimer: Curated by HT Syndication.
